Knoll Capital Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $147 Million distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Aldeyra Therapeutics, Inc. with a value of $21M, Biohaven Pharmaceutical Holding CO Ltd. with a value of $12.6M, Entera Bio Ltd. with a value of $11.2M, Spdr Gold Trust with a value of $9.75M, and Centerra Gold Inc. with a value of $8.85M.

Examining the 13F form we can see an decrease of $2.74M in the current position value, from $150M to 147M.

Knoll Capital Management, LLC is based out at Miami, FL

Below you can find more details about Knoll Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $147 Million
Healthcare: $75 Million
Basic Materials: $51.5 Million
ETFs: $13.8 Million
Consumer Defensive: $2.5 Million
Industrials: $2.44 Million
Financial Services: $1.72 Million

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $147 Million
  • Prior Value $150 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 3 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Knoll Capital Management, LLC Portfolio

Follow Knoll Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Knoll Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Knoll Capital Management, LLC with notifications on news.